TY - JOUR
T1 - ER-to-Golgi transport and SEC23-dependent COPII vesicles regulate T cell alloimmunity
AU - Kim, Stephanie
AU - Khoriaty, Rami
AU - Li, Lu
AU - McClune, Madison
AU - Kalfa, Theodosia A.
AU - Wu, Julia
AU - Peltier, Daniel
AU - Fujiwara, Hideaki
AU - Sun, Yaping
AU - Oravecz-Wilson, Katherine
AU - King, Richard A.
AU - Ginsburg, David
AU - Reddy, Pavan
N1 - Funding Information:
This work was supported by the National Institutes of Health (grants T32GM007863 and F30AI145113 to SK; grant R01HL148333 to RK; grant R35HL135793 to DG; NHLBI grant R01HL128046 and NCI grants R01CA203542 and R01CA217156 to PR). DG is a Howard Hughes Medical Institute Investigator. We would like to thank the University of Michigan Microscopy and Image Analysis Laboratory for processing and acquisition of TEM samples and for the use of instruments for the acquisition of immunofluorescence confocal images. We would also like to thank the University of Michigan Cancer Center Immunology Core for assistance with Luminex Assays, and the University of Michigan Proteomics Resource Facility for processing and analysis of secretome samples.
Publisher Copyright:
Copyright: © 2021, American Society for Clinical Investigation.
PY - 2021/1/19
Y1 - 2021/1/19
N2 - T cell-mediated responses are dependent on their secretion of key effector molecules. However, the critical molecular determinants of the secretion of these proteins are largely undefined. Here, we demonstrate that T cell activation increases trafficking via the ER-to-Golgi pathway. To study the functional role of this pathway, we generated mice with a T cell-specific deletion in SEC23B, a core subunit of coat protein complex II (COPII). We found that SEC23B critically regulated the T cell secretome following activation. SEC23B-deficient T cells exhibited a proliferative defect and reduced effector functions in vitro, as well as in experimental models of allogeneic and xenogeneic hematopoietic cell transplantation in vivo. However, T cells derived from 3 patients with congenital dyserythropoietic anemia II (CDAII), which results from Sec23b mutation, did not exhibit a similar phenotype. Mechanistic studies demonstrated that unlike murine KO T cells, T cells from patients with CDAII harbor increased levels of the closely related paralog, SEC23A. In vivo rescue of murine KO by expression of Sec23a from the Sec23b genomic locus restored T cell functions. Together, our data demonstrate a critical role for the COPII pathway, with evidence for functional overlap in vivo between SEC23 paralogs in the regulation of T cell immunity in both mice and humans.
AB - T cell-mediated responses are dependent on their secretion of key effector molecules. However, the critical molecular determinants of the secretion of these proteins are largely undefined. Here, we demonstrate that T cell activation increases trafficking via the ER-to-Golgi pathway. To study the functional role of this pathway, we generated mice with a T cell-specific deletion in SEC23B, a core subunit of coat protein complex II (COPII). We found that SEC23B critically regulated the T cell secretome following activation. SEC23B-deficient T cells exhibited a proliferative defect and reduced effector functions in vitro, as well as in experimental models of allogeneic and xenogeneic hematopoietic cell transplantation in vivo. However, T cells derived from 3 patients with congenital dyserythropoietic anemia II (CDAII), which results from Sec23b mutation, did not exhibit a similar phenotype. Mechanistic studies demonstrated that unlike murine KO T cells, T cells from patients with CDAII harbor increased levels of the closely related paralog, SEC23A. In vivo rescue of murine KO by expression of Sec23a from the Sec23b genomic locus restored T cell functions. Together, our data demonstrate a critical role for the COPII pathway, with evidence for functional overlap in vivo between SEC23 paralogs in the regulation of T cell immunity in both mice and humans.
UR - http://www.scopus.com/inward/record.url?scp=85099940479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099940479&partnerID=8YFLogxK
U2 - 10.1172/JCI136574
DO - 10.1172/JCI136574
M3 - Article
C2 - 33463537
AN - SCOPUS:85099940479
SN - 0021-9738
VL - 131
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 2
M1 - e136574
ER -